Literature DB >> 11422538

Biology of human papillomaviruses.

H R McMurray1, D Nguyen, T F Westbrook, D J McAnce.   

Abstract

Human papillomaviruses (HPVs) cause squamous cancers of epithelial surfaces, of which genital cancers are the most common. In this article we have attempted to describe the properties and functions of the viral proteins of HPV type 16, a common cause of genital cancers, and have tried to suggest how their expression may lead to a dysregulated cell which may become malignant. These viruses are attempting to replicate in terminally differentiating keratinocytes and must stimulate G1 to S-phase progression for the replication of their genome. As part of the successful completion of replication and assembly of infectious virus particles, the virus needs at least partial differentiation to occur. Therefore, at the same time as differentiation is occurring, the nuclei of infected cells are in S-phase. While the mechanisms of action of the viral proteins are not completely understood, researchers are making progress and this article strives to bring together the conclusions from some of this work.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422538      PMCID: PMC2517699          DOI: 10.1046/j.1365-2613.2001.00177.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  145 in total

Review 1.  Viruses in human cancers.

Authors:  H zur Hausen
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

2.  A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems.

Authors:  J L Adam; M W Briggs; D J McCance
Journal:  Virology       Date:  2000-07-05       Impact factor: 3.616

3.  The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway.

Authors:  K Webster; J Parish; M Pandya; P L Stern; A R Clarke; K Gaston
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

4.  Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.

Authors:  C W Greider; E H Blackburn
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

5.  Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil.

Authors:  D J McCance; A Kalache; K Ashdown; L Andrade; F Menezes; P Smith; R Doll
Journal:  Int J Cancer       Date:  1986-01-15       Impact factor: 7.396

6.  E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage.

Authors:  S Jackson; A Storey
Journal:  Oncogene       Date:  2000-01-27       Impact factor: 9.867

7.  HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.

Authors:  D Pim; M Thomas; R Javier; D Gardiol; L Banks
Journal:  Oncogene       Date:  2000-02-10       Impact factor: 9.867

8.  HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.

Authors:  P Massimi; D Pim; A Storey; L Banks
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

9.  Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix.

Authors:  D J McCance; M J Campion; P K Clarkson; P M Chesters; D Jenkins; A Singer
Journal:  Br J Obstet Gynaecol       Date:  1985-11

10.  Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen.

Authors:  S Huang; N P Wang; B Y Tseng; W H Lee; E H Lee
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  43 in total

1.  HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.

Authors:  Phillip R Heaton; Adeline F Deyrieux; Xue-Lin Bian; Van G Wilson
Journal:  Virus Res       Date:  2011-04-12       Impact factor: 3.303

2.  Further evidence that papillomavirus capsids exist in two distinct conformations.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Thorsten Nowak; Neil D Christensen; Martin Sapp
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70.

Authors:  Luise Florin; Katrin A Becker; Cornelia Sapp; Carsten Lambert; Hüseyin Sirma; Martin Müller; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein.

Authors:  Kwang-Jin Oh; Anna Kalinina; No-Hee Park; Srilata Bagchi
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Cell cycle regulatory protein expression profiles by adenovirus p53 infection in human papilloma virus-associated cervical cancer cells.

Authors:  Yong-Seok Lee; Su-Mi Bae; Sun-Young Kwak; Dong-Chun Park; Yong-Wook Kim; Soo-Young Hur; Eun-Kyung Park; Byoung-Don Han; Young-Joo Lee; Chong-Kook Kim; Do Kang Kim; Woong-Shick Ahn
Journal:  Cancer Res Treat       Date:  2006-06-30       Impact factor: 4.679

7.  Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma.

Authors:  Ni Sima; Liping Cai; Yuanfang Zhu; Wei Wang; Shixuan Wang; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

8.  Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.

Authors:  Claudio Talora; Dennis C Sgroi; Christopher P Crum; G Paolo Dotto
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

Review 9.  Human papillomavirus type 16 E5 protein as a therapeutic target.

Authors:  Sang-Woo Kim; Joo-Sung Yang
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

10.  The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase.

Authors:  Kwang-Jin Oh; Anna Kalinina; Jing Wang; Keiko Nakayama; Keiichi I Nakayama; Srilata Bagchi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.